Skip to content
AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
45,885
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,241
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Taxol Oxytocin Morphine (?)-nicotine Testosterone Melatonin Caffeine L-ascorbic acid Progesterone Coumarins
⚗️ Ingredient

Oroxin a

Open on HERB 2.0 ↗
16
Clinical Trials
0
Meta-Analyses
0
PubMed References
Top Conditions Studied with Oroxin a
Healthy Volunteers 4 Cellulitis 3 Anti-Infective Agents 2 Infections, Respiratory Tract 2 Staphylococcal Infection|Abscess|Staphylococcal Skin Infecti 1 Osteomyelitis|Septic Arthritis|Pyomyositis 1 Neonatal Infection 1 Mild to Moderate Uncomplicated Skin and Skin Structure Infec 1 Healthy 1
📋 Sample Trials
NCT00234949
A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections
Completed · Phase 4
NCT00352612
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
Completed · Phase 4
NCT02100826
A Study of Cephalexin in Healthy Participants
Completed · Phase 1
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Oroxin a
⚗️ Identity
Name
Oroxin a
Aliases / Synonyms
57396-78-8; baicalein-7-o-glucoside; 5,6-dihydroxy-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; baicalein 7-O-glucoside; OroxinA; Baicalein-7-O-glucoside; Baikalin; Baicalein 7-O-glucopyranoside; CHEMBL516858; SCHEMBL6238244
🧪 Chemistry
Molecular Weight
432.3810
LogP
0.0499
Drug-likeness
0.31
Oral Bioavailability
9.5820
H-Bond Acceptors
10
H-Bond Donors
6
Rotatable Bonds
4
🔬 Structures
Canonical SMILES
C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O
Isomeric SMILES
C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O
InChIKey
IPQKDIRUZHOIOM-IAAKTDFRSA-N
InChI
InChI=1S/C21H20O10/c22-8-14-17(25)19(27)20(28)21(31-14)30-13-7-12-15(18(26)16(13)24)10(23)6-11(29-12)9-4-2-1-3-5-9/h1-7,14,17,19-22,24-28H,8H2/t14-,17-,19+,20-,21-/m1/s1
🔗 External References
HERB DB
HBIN038299 ↗
PubChem CID
5320313 ↗
CAS Number
57396-78-8 ↗
SymMap
10840
TCMID
31760
TCMSP
MOL009754
TCM-ID
1894
🔍 Raw view — every non-empty column on this row (32 fields)
name
Oroxin a
common names
57396-78-8; baicalein-7-o-glucoside; 5,6-dihydroxy-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; baicalein 7-O-glucoside; OroxinA; Baicalein-7-O-glucoside; Baikalin; Baicalein 7-O-glucopyranoside; CHEMBL516858; SCHEMBL6238244
herb ingredient id
HBIN038299
canonical smiles
C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O
isomeric smiles
C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O
inchi
InChI=1S/C21H20O10/c22-8-14-17(25)19(27)20(28)21(31-14)30-13-7-12-15(18(26)16(13)24)10(23)6-11(29-12)9-4-2-1-3-5-9/h1-7,14,17,19-22,24-28H,8H2/t14-,17-,19+,20-,21-/m1/s1
inchikey
IPQKDIRUZHOIOM-IAAKTDFRSA-N
mol wt
432.3810
num h acceptors
10
num h donors
6
mol logp
0.0499
num rotatable bonds
4
drug likeness
0.31
ob score
9.5820
cas id
57396-78-8
symmap mol id
10840
tcmid ingredient id
31760
tcmsp ingredient id
MOL009754
tcm id ingredient id
1894
pubchem cid
5320313

📋 Clinical Trials

12 · subject of clinical study
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate
→ Mild to Moderate Uncomplicated Skin and Skin Struc
NCT00352612 Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infection
→ Staphylococcal Infection|Abscess|Staphylococcal Sk
NCT02100826 A Study of Cephalexin in Healthy Participants
→ Healthy Volunteers
NCT02490670 A Study of Cephalexin Liquid in Healthy Participants
→ Healthy
NCT01029782 Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin fo
→ Cellulitis
NCT01073540 Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspens
→ Anti-Infective Agents
NCT01105208 Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspens
→ Anti-Infective Agents
NCT01767532 Bioequivalence Study of Cephalexin Suspension 125
→ Infections, Respiratory Tract
NCT01767571 Bioequivalence Study of Cephalexin Suspension 250
→ Infections, Respiratory Tract
NCT02123446 A Study of Cephalexin Capsules in Healthy Participants
→ Healthy Volunteers
NCT02123459 A Study of Cephalexin Suspension in Healthy Participants
→ Healthy Volunteers
NCT02123472 A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants
→ Healthy Volunteers

How to read these connections

Each box lists records connected to the one you are viewing, and says how the connection was made. A connection shows that two records are related in the source data. It does not show that something works, is safe or should be used, and a record with many connections is not necessarily better studied or more effective.

  • Study records (trials, systematic reviews, publications): the study names this subject. Registered or ongoing studies have no results here, and animal or cell research does not show an effect in people.
  • Source-database links (for example herb and compound, compound and gene target): taken from the imported databases and not independently checked by us.
  • Name matches (for example formula and herb, or a condition named in a study): found by matching names, so they can be wrong. Treat them as leads, not findings.

Read the full guide to these records · Search study records